CBDL.D Stock Overview
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CBD Life Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0063 |
| 52 Week High | US$0.03 |
| 52 Week Low | US$0.0003 |
| Beta | 0 |
| 1 Month Change | -79.07% |
| 3 Month Change | -79.07% |
| 1 Year Change | 1,993.33% |
| 3 Year Change | -98.26% |
| 5 Year Change | -99.78% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDL.D | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -79.1% | 0.7% | 2.9% |
| 1Y | 1,993.3% | 10.8% | 22.2% |
Return vs Industry: CBDL.D exceeded the US Pharmaceuticals industry which returned 10.8% over the past year.
Return vs Market: CBDL.D exceeded the US Market which returned 22.2% over the past year.
Price Volatility
| CBDL.D volatility | |
|---|---|
| CBDL.D Average Weekly Movement | 7,399.3% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBDL.D's share price has been volatile over the past 3 months.
Volatility Over Time: CBDL.D's weekly volatility has decreased from 7715% to 7399% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 6 | Lisa Nelson | lbcbioscienceinc.com |
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
CBD Life Sciences Inc. Fundamentals Summary
| CBDL.D fundamental statistics | |
|---|---|
| Market cap | US$973.52k |
| Earnings (TTM) | -US$3.22m |
| Revenue (TTM) | US$138.19k |
0.0x
P/S Ratio0.0x
P/E RatioIs CBDL.D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDL.D income statement (TTM) | |
|---|---|
| Revenue | US$138.19k |
| Cost of Revenue | US$73.52k |
| Gross Profit | US$64.67k |
| Other Expenses | US$3.28m |
| Earnings | -US$3.22m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CBDL.D perform over the long term?
See historical performance and comparison